A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(219 sites)

United States

Cullman Clinical Trials ( Site 3813), Cullman, Alabama

Helios Clinical Research ( Site 3826), Paradise Valley, Arizona

Absolute Clinical Research ( Site 3709), Phoenix, Arizona

Clinica de Salud del Valle de Salinas ( Site 3825), Castroville, California

Ascada Health PC dba Ascada Research ( Site 3750), Fullerton, California